Norris Perne & French LLP Medpace Holdings, Inc. Transaction History

Norris Perne & French LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 16, 2020	SELL	$61.71 - $101.95 $6.96 Million - $11.5 Million	-112,839 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$70.08 - $84.64 $82,624 - $99,790	1,179 Added 1.06%	112,839 $9.49 Million
Q3 2019 Oct 24, 2019	SELL	$62.38 - $85.89 $130,748 - $180,025	-2,096 Reduced 1.84%	111,660 $9.38 Million
Q2 2019 Jul 19, 2019	BUY	$53.64 - $65.42 $216,544 - $264,100	4,037 Added 3.68%	113,756 $7.44 Million
Q1 2019 Apr 29, 2019	BUY	$49.38 - $70.58 $5.42 Million - $7.74 Million	109,719 New	109,719 $6.47 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

Stay updated on Norris Perne & French LLP with notifications on news.